OncoMed Pharmaceuticals Promotes John Lewicki to CEO

OncoMed Pharmaceuticals Promotes John Lewicki to CEO
By: biot11 Posted On: March 30, 2018 View: 314

OncoMed Pharmaceuticals Promotes John Lewicki to CEO

Xconomy San Francisco — 

OncoMed Pharmaceuticals (NASDAQ: OMED) is expanding the responsibilities of its president, John Lewicki, to include chief executive. Lewicki was appointed president of the Redwood City, CA, cancer drug developer in January. With his promotion to CEO, Lewicki also joins OncoMed’s board of directors. Lewicki came to OncoMed in 2004 as senior vice president of research and development and moved to other roles in the company in subsequent years. Last year, OncoMed’s two lead drugs failed in clinical trials. The company’s pipeline currently holds six clinical-stage compounds.

Frank Vinluan is editor of Xconomy Raleigh-Durham, based in Research Triangle Park. You can reach him at fvinluan [at] Follow @frankvinluan

Trending on Xconomy

  Contact Us

Botawala Chambers , Fort-Mumbai

Tel : + (91) - 8484924178
Mail :
Business Hours : 9:30 - 5:30


Dailyagronews is a dedicated platform for Exclusive Agriculture News , Now stay in touch with latest happenings in Agriculture . This site is a work of team of technocrafts wanted to help the farming community by contributing something helpful to them. Join this unique platform by contributing the agro news , we will be happy to make it viral